Filing Details

Accession Number:
0001213900-25-013802
Form Type:
13G Filing
Publication Date:
2025-02-13 19:00:00
Filed By:
Rodney Hodges
Company:
Polypid Ltd. (NASDAQ:PYPD)
Filing Date:
2025-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Rodney Hodges 0 2,242,767 19.9%
POD Sarl 0 2,242,767 19.9%
Geneva Holding Company (GHC) SA 0 2,242,767 19.9%
Geneva Trust Company (GTC) SA 0 2,242,767 19.9%
Centaurus Investments Limited 0 2,210,717 19.6%
Xenia Venture Capital Limited 0 1,711,792 15.5%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  (1) Includes 860,764 warrants held by Xenia Venture Capital Limited and 274,471 warrants held by Oriella Limited, exercisable within 60 days of February 14, 2025. (2) Percentage is based on the 10,190,904 Ordinary Shares of the Issuer that were outstanding as of January 17, 2025, based on information contained in the Form F-3 filed by the Issuer on January 21, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  (1) Includes 860,764 warrants held by Xenia Venture Capital Limited and 274,471 warrants held by Oriella Limited, exercisable within 60 days of February 14, 2025. (2) Percentage is based on the 10,190,904 Ordinary Shares of the Issuer that were outstanding as of January 17, 2025, based on information contained in the Form F-3 filed by the Issuer on January 21, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  (1) Includes 860,764 warrants held by Xenia Venture Capital Limited and 274,471 warrants held by Oriella Limited, exercisable within 60 days of February 14, 2025. (2) Percentage is based on the 10,190,904 Ordinary Shares of the Issuer that were outstanding as of January 17, 2025, based on information contained in the Form F-3 filed by the Issuer on January 21, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  (1) Includes 860,764 warrants held by Xenia Venture Capital Limited and 274,471 warrants held by Oriella Limited, exercisable within 60 days of February 14, 2025. (2) Percentage is based on the 10,190,904 Ordinary Shares of the Issuer that were outstanding as of January 17, 2025, based on information contained in the Form F-3 filed by the Issuer on January 21, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  (1) Includes 860,764 warrants held by Xenia Venture Capital Limited and 274,471 warrants held by Oriella Limited, exercisable within 60 days of February 14, 2025. (2) Percentage is based on the 10,190,904 Ordinary Shares of the Issuer that were outstanding as of January 17, 2025, based on information contained in the Form F-3 filed by the Issuer on January 21, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  (1) Includes 860,764 warrants held by Xenia Venture Capital Limited, exercisable within 60 days of February 14, 2025. (2) Percentage is based on the 10,190,904 Ordinary Shares of the Issuer that were outstanding as of January 17, 2025, based on information contained in the Form F-3 filed by the Issuer on January 21, 2025.


SCHEDULE 13G


 
Rodney Hodges
 
Signature:/s/ Rodney Hodges
Name/Title:Rodney Hodges
Date:02/14/2025
 
POD Sarl
 
Signature:/s/ Rodney Hodges
Name/Title:Rodney Hodges/Authorized Signatory
Date:02/14/2025
 
Geneva Holding Company (GHC) SA
 
Signature:/s/ Rodney Hodges
Name/Title:Rodney Hodges/Authorized Signatory
Date:02/14/2025
 
Signature:/s/ Tobias Reinmann
Name/Title:Tobias Reinmann/Authorized Signatory
Date:02/14/2025
 
Geneva Trust Company (GTC) SA
 
Signature:/s/ Rodney Hodges
Name/Title:Rodney Hodges/Authorized Signatory
Date:02/14/2025
 
Signature:/s/ Tobias Reinmann
Name/Title:Tobias Reinmann/Authorized Signatory
Date:02/14/2025
 
Centaurus Investments Limited
 
Signature:/s/ Rodney Hodges
Name/Title:Rodney Hodges/Authorized Signatory for and on behalf of Champel Directors Limited
Date:02/14/2025
 
Signature:/s/ Tobias Reinmann
Name/Title:Tobias Reinmann/Authorized Signatory for and on behalf of Florissant Global Limited
Date:02/14/2025
 
Xenia Venture Capital Limited
 
Signature:/s/ Eli Sorzon
Name/Title:Eli Sorzon/Authorized Signatory
Date:02/14/2025
Exhibit Information

99.1 Joint Filing Agreement, dated September 20, 2023, among Rodney Hodges, Geneva Holding Company (GHC) SA, Geneva Trust Company (GTC) SA, Centaurus Investments Limited, POD Sarl and Xenia Capital Limited (incorporated by reference to Exhibit 99.1 to the Schedule 13G filed Centaurus Investments Limited by on September 20, 2023). https://www.sec.gov/Archives/edgar/data/1611842/000121390023078066/ea185222ex99-1_polypid.htm